Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Hillerod Hospital, Denmark | OTHER |
| Herlev and Gentofte Hospital | OTHER |
Not provided
Not provided
Not provided
Not provided
Pulmonary rehabilitation (PR) is a cornerstone of care for people with COPD. There is robust evidence that PR improves exercise capacity, enhances health-related quality of life (QoL) and reduces healthcare utilization. PR is strongly recommended in guidelines for COPD management. Despite the compelling evidence for its benefits, PR is delivered to less than 30% of people with COPD. Access is particularly challenging, an especially for those with the most progressed disease stages.
We recently completed a randomized clinical trial, showing that approximately 1.100 patients annually are offered conventional hospital-based PR during routine consultations in the Capital Region of Denmark, but at least 700 patients declines participation.
No major cohort studies have been published from people with severe and advanced COPD who opt out of traditional pulmonary rehabilitation. By establishing such cohort study, objective and qualitative knowledge from assessments and patient interviews is collected in patients we have very limited access to and knowledge of. Additionally, the collected data will give a deeper insight and understanding and possibly enable us to design new delivery models to be tested in proper study designs.
Objective This cohort study aims to describe and understand differences and similarities in characteristics among people with severe and advanced COPD who opt-in or opt out of PR services.
The study includes data from: socio-demographic, anthropometric, physical (function, activity, muscle strength, balance) characteristics as well as self-reported symptoms of anxiety, depression, fatigue, pain, lung symptoms, quality of life, sleep-quality, mortality, hospitaladmissions, length of stay and qualitative patient interviews.
Data from our completed trial study (NCT02667171) will be used as the opt-in PR comparison cohort.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Decliners of Pulmonary Rehabilitation | No intervention, just observation |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| No Intervention, just observation | Other | No Intervention, just observation |
|
| Measure | Description | Time Frame |
|---|---|---|
| COPD Assessment Test (CAT) | Observation of changes in points. Lower score indicates improvement | baseline and 52 weeks reassessment, (potentially 104 weeks reassessment) |
| Measure | Description | Time Frame |
|---|---|---|
| 6-Minute Walk Test Distance (6MWD) | Observation of changes i meters. High is better | baseline and 52 weeks reassessment, (potentially 104 weeks reassessment) |
| Hospital Anxiety and Depression Scale (HADS) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
This is a prospective observational study of patients with COPD who declines participation in a conventional out-patient hospital-based PR program.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Charlotte Suppli Ulrik, MD, DMSc | Hvidovre University Hospital, Respiratory Department and Research Unit | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Bispebjerg and Frederiksberg University Hospital | Copenhagen | Copenhagen North West | 2400 | Denmark | ||
Proposal for data use should be addressed to Henrik.hansen.09@regionh.dk
Data access in Denmark are under very strict juristic data protection law.
Any possible access or sharing demands a part application to
Only if the applications are approved data will be considered available for sharing. The authors will not be able to support this process and a prolonged process must be expected.
unresolved
Please read plan description
Not provided
Not provided
| ID | Term |
|---|---|
| D029424 | Pulmonary Disease, Chronic Obstructive |
| ID | Term |
|---|---|
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D002908 | Chronic Disease |
Not provided
Not provided
Not provided
Not provided
Not provided
Observation of changes in point. Low score is better
| baseline and 52 weeks reassessment, (potentially 104 weeks reassessment) |
| Euro-Qol (EQ5D) | Observation of changes in Visual analogue scale (VAS). Higher VAS is better | baseline and 52 weeks reassessment, (potentially 104 weeks reassessment) |
| Brief Pain Inventory (BPI) | Observation of changes in points. Low is better | baseline and 52 weeks reassessment, (potentially 104 weeks reassessment) |
| Multidimensional Fatigue Inventory (MFI-20) | Observation of changes in points. Low is better | baseline and 52 weeks reassessment, (potentially 104 weeks reassesment) |
| Short Physical Performance Battery (SPPB) | Observation of changes in point. High is better | baseline and 52 weeks reassessment, (potentially 104 weeks reassessment) |
| Hand-Grip Strength (JAMAR) | Observation of changes in kilo. High is better | baseline and 52 weeks reassessment, (potentially 104 weeks reassessment) |
| 30 seconds sit-to-stand test (30sec-STS) | Observation of changes in repetitions. High is better | baseline and 52 weeks reassessment, (potentially 104 weeks reassessment) |
| Pittsburgh Sleep Quality Index (PSQI) | Observation of changes in point. Low score is better | baseline and 52 weeks reassessment, (potentially 104 weeks reassessment) |
| Number of hospital admissions (respiratory and all-cause) | Observation of changes in actual numbers. Low is better | baseline and 52 weeks reassessment, (potentially 104 weeks reassessment) |
| Length of hospital admissions (respiratory and all-cause) | Observation of changes in days. Low is better | baseline and 52 weeks reassessment, (potentially 104 weeks reassessment) |
| Out-patient visits | Observation of changes in actual number. Low is better | baseline and 52 weeks reassessment, (potentially 104 weeks reassessment) |
| Mortality (respiratory and all-cause) | Observation of changes as number of deaths. Low is better | baseline and 52 weeks reassessment, (potentially 104 weeks reassesment) |
| Timed Up and Go Test | Observation of changes in seconds. Low is better | baseline and 52 weeks reassessment, (potentially 104 weeks reassessment) |
| Activity level (ActivPAL) | Observation of changes in steps per day. High is better | baseline and 52 weeks reassessment, (potentially 104 weeks reassessment) - Worn by the patients around the clock for 5 days |
| Amager and Hvidovre University Hospital |
| Hvidovre |
| Danmark |
| 2650 |
| Denmark |
| Gentofte and Herlev University Hospital | Gentofte Municipality | Hellerup | 2900 | Denmark |
| Nordsjaelland University Hospital | Hillerød | 3400 | Denmark |
| D020969 |
| Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |